Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SB/Bristol Avandia Co-Promotion Unveiled Following Cmte. Recommendation

Executive Summary

The Avandia co-promotion agreement between SmithKline Beecham and Bristol-Myers Squibb in the U.S. draws on Bristol's market knowledge in the diabetes field and the complex synergy of Bristol's Glucophage and the new SB agent.

You may also be interested in...



CV Therapeutics Ranexa Pre-Launch Steps Will Ramp Up After Cmte. Review

CV Therapeutics expects to begin hiring Ranexa sales reps following the chronic angina therapy's review by FDA's Cardiovascular & Renal Drugs Advisory Committee in September, the company said July 17

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
UsernamePublicRestriction

Register

PS034061

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel